文献速递头颈外科

HPV相关口咽癌风险增高个体临床评估的可行性

Feasibility of clinical evaluation of individuals with increased risk for HPV-associated oropharynx cancer.
PubMed 文献 · Head Neck · 2022-10-06

本研究为前瞻性研究(MOUTH),纳入具有HPV相关口咽鳞状细胞癌(HPV-OPSCC)危险因素的个体,评估在筛查研究中对生物标志物阳性者进行临床评估(头颈部检查及超声和/或磁共振成像)的可行性。384名符合临床评估条件的参与者中,204人(53%)完成了头颈部检查或影像学检查;其中66人(32%)完成了磁共振成像(n=51)和/或超声(n=64)检查。结论认为,在HPV-OPSCC筛查研究背景下,包括头颈部检查和影像学在内的临床评估是可行的。

要点

  • 384名符合临床评估条件的参与者中,204人(53%)完成了头颈部检查或影像学检查。
  • 完成临床评估的204人中,66人(32%)完成了磁共振成像(n=51)和/或超声(n=64)检查。
  • 在HPV-OPSCC筛查研究背景下,包括头颈部检查和影像学在内的临床评估是可行的。

核心结论

  • 在HPV-OPSCC筛查研究背景下,包括头颈部检查和影像学在内的临床评估是可行的。

研究设计与样本

  • 前瞻性研究(MOUTH),纳入具有HPV-OPSCC危险因素的个体,生物标志物阳性者符合临床评估条件。

主要发现

  • 384名参与者符合临床评估条件,其中204人(53%)完成了头颈部检查或影像学检查。
  • 完成临床评估的204人中,66人(32%)完成了磁共振成像(n=51)和/或超声(n=64)检查。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Human papillomavirus-associated oropharynx squamous cell carcinoma (HPV-OPSCC) has no known pre-malignant lesion. While vaccination offers future primary prevention, there is current interest in secondary prevention. The feasibility of clinical evaluation of individuals at increased risk for HPV-OPSCC is unclear. METHODS: Individuals with risk factors for HPV-OPSCC were enrolled in a prospective study (MOUTH). Participants positive for biomarkers associated with HPV-OPSCC were eligible for a clinical evaluation which comprised a head and neck examination and imaging with ultrasound and/or magnetic resonance imaging (MRI). This study was designed to evaluate feasibility of clinical evaluation in a screening study. RESULTS: Three hundred and eighty-four participants were eligible for clinical evaluation. Of the 384, 204 (53%) completed a head and neck examination or imaging. Of these, 66 (32%) completed MRI (n = 51) and/or ultrasound (n = 64) studies. CONCLUSIONS: Clinical evaluations, including head and neck examination and imaging, are feasible in the context of a screening study for HPV-OPSCC.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Scott-Wittenborn N, D'Souza G, Aygun N, et al. Feasibility of clinical evaluation of individuals with increased risk for HPV-associated oropharynx cancer. Head Neck. 2022. PMID: 36200696. doi:10.1002/hed.27212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。